228 related articles for article (PubMed ID: 24072036)
1. Rare e14a3 (b3a3) BCR-ABL fusion in chronic myeloid leukemia in India: the threats and challenges in monitoring minimal residual disease (MRD).
Vaniawala S; Acharya A; Parekh H; Mukhopadhyaya PN
Anal Cell Pathol (Amst); 2013; 36(3-4):85-92. PubMed ID: 24072036
[TBL] [Abstract][Full Text] [Related]
2. A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: diagnostic challenges in clinical laboratory practice.
Jinawath N; Norris-Kirby A; Smith BD; Gocke CD; Batista DA; Griffin CA; Murphy KM
J Mol Diagn; 2009 Jul; 11(4):359-63. PubMed ID: 19497989
[TBL] [Abstract][Full Text] [Related]
3. How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review.
Hu LH; Pu LF; Yang DD; Zhang C; Wang HP; Ding YY; Li MM; Zhai ZM; Xiong S
Oncol Lett; 2017 Nov; 14(5):5619-5623. PubMed ID: 29113191
[TBL] [Abstract][Full Text] [Related]
4. [Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].
Link-Lenczowska D; Sacha T; Zawada M; Czekalska S; Florek I; Skotnicki AB
Przegl Lek; 2014; 71(5):258-62. PubMed ID: 25248240
[TBL] [Abstract][Full Text] [Related]
5. Breakpoint mapping of a t(9;22;12) chronic myeloid leukaemia patient with e14a3 BCR-ABL1 transcript using Nanopore sequencing.
Zhao H; Chen Y; Shen C; Li L; Li Q; Tan K; Huang H; Hu G
J Gene Med; 2021 Jan; 23(1):e3276. PubMed ID: 32949441
[TBL] [Abstract][Full Text] [Related]
6. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
[TBL] [Abstract][Full Text] [Related]
7. [Application of Real-time Quantitative PCR in Detecting Atypical BCR/ABL mRNA Transcripts in Chronic Myelocytic Leukemia].
Zou Y; DU C; Chen HM; Guo FX; Cheng JB; Tang YY; Wu W; Xia CQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1016-1021. PubMed ID: 28823261
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].
Qian SX; Li JY; Zhang R; Hong M; Qiu HR; Li L; Xu W; Sheng RL; Wu HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):577-81. PubMed ID: 16800946
[TBL] [Abstract][Full Text] [Related]
9. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
[TBL] [Abstract][Full Text] [Related]
10. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease.
Bose S; Deininger M; Gora-Tybor J; Goldman JM; Melo JV
Blood; 1998 Nov; 92(9):3362-7. PubMed ID: 9787174
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Molecular Remission after Treatment with Imatinib in a Chronic Myeloid Leukemia Patient with Extreme Thrombocytosis Harboring Rare e14a3 (b3a3) BCR::ABL1 Transcript: A Case Report.
Zhang X; Sun H; Su Y; Yi H
Curr Oncol; 2022 Oct; 29(11):8171-8179. PubMed ID: 36354705
[TBL] [Abstract][Full Text] [Related]
12. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
Bennour A; Ouahchi I; Achour B; Zaier M; Youssef YB; Khelif A; Saad A; Sennana H
Med Oncol; 2013 Mar; 30(1):348. PubMed ID: 23269583
[TBL] [Abstract][Full Text] [Related]
14. Novel e8a2 BCR/ABL Fusion Transcript in Case of a Myeloproliferative Neoplasm.
Panigrahi MK; Kumar D; Mehta A; Suryavanshi M; Bhurani D; Saikia KK
Indian J Hematol Blood Transfus; 2017 Jun; 33(2):271-272. PubMed ID: 28596663
[TBL] [Abstract][Full Text] [Related]
15. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
Preudhomme C; Chams-Eddine L; Roumier C; Duflos-Grardel N; Denis C; Cosson A; Fenaux P
Leukemia; 1999 May; 13(5):818-23. PubMed ID: 10374889
[TBL] [Abstract][Full Text] [Related]
16. A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia.
Grand FH; Chase A; Iqbal S; Nguyen DX; Lewis JL; Marley SB; Davidson RJ; Goldman JM; Gordon MY
Genes Chromosomes Cancer; 1998 Oct; 23(2):109-15. PubMed ID: 9739013
[TBL] [Abstract][Full Text] [Related]
17. The molecular biology of chronic myeloid leukaemia.
Melo JV
Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Langenhuijsen MM; Ossenkoppele GJ
Leukemia; 1997 Feb; 11(2):301-5. PubMed ID: 9009097
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization].
Song YQ; Li W; Kong LH; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):38-40. PubMed ID: 12667287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
